Will NVIDIA Return to Its 52-Week High?
NVIDIA (NASDAQ:NVDA) has been among the best-performing investments of the…
Sell
30
SMGRF Quote, Financials, Valuation and Earnings
Last price:
$9.45
Seasonality move
:
4.71%
Day range:
$9.45 - $9.45
52-week range:
$9.45 - $9.45
Dividend yield:
1.55%
P/E ratio:
11.05x
P/S ratio:
11.74x
P/B ratio:
1.36x
Volume:
--
Avg. volume:
--
1-year change:
--
Market cap:
$2.3B
Revenue:
$192.5M
EPS (TTM):
$0.86
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
SMGRF
Summerset Group Holdings
|
-- | -- | -- | -- | -- |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare
|
-- | -- | -- | -- | -- |
|
PFGTF
Pacific Edge
|
-- | -- | -- | -- | -- |
|
PRCXF
Green Cross Health
|
-- | -- | -- | -- | -- |
|
RHCGF
Ryman Healthcare
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
SMGRF
Summerset Group Holdings
|
$9.45 | -- | $2.3B | 11.05x | $0.08 | 1.55% | 11.74x |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | $0.00 | 0% | -- |
|
FSPKF
Fisher & Paykel Healthcare
|
$16.35 | -- | $9.6B | 62.70x | $0.11 | 1.54% | 8.96x |
|
PFGTF
Pacific Edge
|
$0.08 | -- | $64.1M | -- | $0.00 | 0% | 4.38x |
|
PRCXF
Green Cross Health
|
$0.70 | -- | $100.5M | 13.94x | $0.01 | 0% | 0.32x |
|
RHCGF
Ryman Healthcare
|
$1.41 | -- | $705M | -- | $0.00 | 0% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
SMGRF
Summerset Group Holdings
|
36.6% | -0.028 | 43.27% | 0.11x |
|
AROAF
Aroa Biosurgery
|
-- | 0.000 | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare
|
7.25% | 1.233 | 0.64% | 0.99x |
|
PFGTF
Pacific Edge
|
7.56% | -4.587 | 4.07% | 4.87x |
|
PRCXF
Green Cross Health
|
47.81% | 0.000 | 83.12% | 0.44x |
|
RHCGF
Ryman Healthcare
|
-- | -0.138 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
SMGRF
Summerset Group Holdings
|
-- | -- | 5.8% | 12.83% | -- | -- |
|
AROAF
Aroa Biosurgery
|
-- | -- | -- | -- | -- | -- |
|
FSPKF
Fisher & Paykel Healthcare
|
-- | -- | 8.89% | 9.85% | -- | -- |
|
PFGTF
Pacific Edge
|
-- | -- | -54.77% | -56.46% | -- | -- |
|
PRCXF
Green Cross Health
|
-- | -- | 4.37% | 7.12% | -- | -- |
|
RHCGF
Ryman Healthcare
|
-- | -- | -- | -- | -- | -- |
Summerset Group Holdings vs. Competitors
-
Which has Higher Returns SMGRF or AROAF?
Aroa Biosurgery has a net margin of -- compared to Summerset Group Holdings's net margin of --. Summerset Group Holdings's return on equity of 12.83% beat Aroa Biosurgery's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SMGRFSummerset Group Holdings-- -- $2.6B AROAFAroa Biosurgery-- -- -- -
What do Analysts Say About SMGRF or AROAF?
Summerset Group Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Aroa Biosurgery has an analysts' consensus of -- which suggests that it could fall by --. Given that Summerset Group Holdings has higher upside potential than Aroa Biosurgery, analysts believe Summerset Group Holdings is more attractive than Aroa Biosurgery.
Company Buy Ratings Hold Ratings Sell Ratings SMGRFSummerset Group Holdings0 0 0 AROAFAroa Biosurgery0 0 0 -
Is SMGRF or AROAF More Risky?
Summerset Group Holdings has a beta of -0.401, which suggesting that the stock is 140.118% less volatile than S&P 500. In comparison Aroa Biosurgery has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SMGRF or AROAF?
Summerset Group Holdings has a quarterly dividend of $0.08 per share corresponding to a yield of 1.55%. Aroa Biosurgery offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Summerset Group Holdings pays 9.87% of its earnings as a dividend. Aroa Biosurgery pays out -- of its earnings as a dividend. Summerset Group Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMGRF or AROAF?
Summerset Group Holdings quarterly revenues are --, which are smaller than Aroa Biosurgery quarterly revenues of --. Summerset Group Holdings's net income of -- is lower than Aroa Biosurgery's net income of --. Notably, Summerset Group Holdings's price-to-earnings ratio is 11.05x while Aroa Biosurgery's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Summerset Group Holdings is 11.74x versus -- for Aroa Biosurgery. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMGRFSummerset Group Holdings11.74x 11.05x -- -- AROAFAroa Biosurgery-- -- -- --
-
Which has Higher Returns SMGRF or FSPKF?
Fisher & Paykel Healthcare has a net margin of -- compared to Summerset Group Holdings's net margin of --. Summerset Group Holdings's return on equity of 12.83% beat Fisher & Paykel Healthcare's return on equity of 9.85%.
Company Gross Margin Earnings Per Share Invested Capital SMGRFSummerset Group Holdings-- -- $2.6B FSPKFFisher & Paykel Healthcare-- -- $1.3B -
What do Analysts Say About SMGRF or FSPKF?
Summerset Group Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Fisher & Paykel Healthcare has an analysts' consensus of -- which suggests that it could fall by --. Given that Summerset Group Holdings has higher upside potential than Fisher & Paykel Healthcare, analysts believe Summerset Group Holdings is more attractive than Fisher & Paykel Healthcare.
Company Buy Ratings Hold Ratings Sell Ratings SMGRFSummerset Group Holdings0 0 0 FSPKFFisher & Paykel Healthcare0 0 0 -
Is SMGRF or FSPKF More Risky?
Summerset Group Holdings has a beta of -0.401, which suggesting that the stock is 140.118% less volatile than S&P 500. In comparison Fisher & Paykel Healthcare has a beta of 1.077, suggesting its more volatile than the S&P 500 by 7.655%.
-
Which is a Better Dividend Stock SMGRF or FSPKF?
Summerset Group Holdings has a quarterly dividend of $0.08 per share corresponding to a yield of 1.55%. Fisher & Paykel Healthcare offers a yield of 1.54% to investors and pays a quarterly dividend of $0.11 per share. Summerset Group Holdings pays 9.87% of its earnings as a dividend. Fisher & Paykel Healthcare pays out 109.73% of its earnings as a dividend. Summerset Group Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Fisher & Paykel Healthcare's is not.
-
Which has Better Financial Ratios SMGRF or FSPKF?
Summerset Group Holdings quarterly revenues are --, which are smaller than Fisher & Paykel Healthcare quarterly revenues of --. Summerset Group Holdings's net income of -- is lower than Fisher & Paykel Healthcare's net income of --. Notably, Summerset Group Holdings's price-to-earnings ratio is 11.05x while Fisher & Paykel Healthcare's PE ratio is 62.70x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Summerset Group Holdings is 11.74x versus 8.96x for Fisher & Paykel Healthcare. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMGRFSummerset Group Holdings11.74x 11.05x -- -- FSPKFFisher & Paykel Healthcare8.96x 62.70x -- --
-
Which has Higher Returns SMGRF or PFGTF?
Pacific Edge has a net margin of -- compared to Summerset Group Holdings's net margin of --. Summerset Group Holdings's return on equity of 12.83% beat Pacific Edge's return on equity of -56.46%.
Company Gross Margin Earnings Per Share Invested Capital SMGRFSummerset Group Holdings-- -- $2.6B PFGTFPacific Edge-- -- $27.9M -
What do Analysts Say About SMGRF or PFGTF?
Summerset Group Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Pacific Edge has an analysts' consensus of -- which suggests that it could fall by --. Given that Summerset Group Holdings has higher upside potential than Pacific Edge, analysts believe Summerset Group Holdings is more attractive than Pacific Edge.
Company Buy Ratings Hold Ratings Sell Ratings SMGRFSummerset Group Holdings0 0 0 PFGTFPacific Edge0 0 0 -
Is SMGRF or PFGTF More Risky?
Summerset Group Holdings has a beta of -0.401, which suggesting that the stock is 140.118% less volatile than S&P 500. In comparison Pacific Edge has a beta of -2.263, suggesting its less volatile than the S&P 500 by 326.301%.
-
Which is a Better Dividend Stock SMGRF or PFGTF?
Summerset Group Holdings has a quarterly dividend of $0.08 per share corresponding to a yield of 1.55%. Pacific Edge offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Summerset Group Holdings pays 9.87% of its earnings as a dividend. Pacific Edge pays out -- of its earnings as a dividend. Summerset Group Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMGRF or PFGTF?
Summerset Group Holdings quarterly revenues are --, which are smaller than Pacific Edge quarterly revenues of --. Summerset Group Holdings's net income of -- is lower than Pacific Edge's net income of --. Notably, Summerset Group Holdings's price-to-earnings ratio is 11.05x while Pacific Edge's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Summerset Group Holdings is 11.74x versus 4.38x for Pacific Edge. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMGRFSummerset Group Holdings11.74x 11.05x -- -- PFGTFPacific Edge4.38x -- -- --
-
Which has Higher Returns SMGRF or PRCXF?
Green Cross Health has a net margin of -- compared to Summerset Group Holdings's net margin of --. Summerset Group Holdings's return on equity of 12.83% beat Green Cross Health's return on equity of 7.12%.
Company Gross Margin Earnings Per Share Invested Capital SMGRFSummerset Group Holdings-- -- $2.6B PRCXFGreen Cross Health-- -- $198.2M -
What do Analysts Say About SMGRF or PRCXF?
Summerset Group Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Green Cross Health has an analysts' consensus of -- which suggests that it could fall by --. Given that Summerset Group Holdings has higher upside potential than Green Cross Health, analysts believe Summerset Group Holdings is more attractive than Green Cross Health.
Company Buy Ratings Hold Ratings Sell Ratings SMGRFSummerset Group Holdings0 0 0 PRCXFGreen Cross Health0 0 0 -
Is SMGRF or PRCXF More Risky?
Summerset Group Holdings has a beta of -0.401, which suggesting that the stock is 140.118% less volatile than S&P 500. In comparison Green Cross Health has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock SMGRF or PRCXF?
Summerset Group Holdings has a quarterly dividend of $0.08 per share corresponding to a yield of 1.55%. Green Cross Health offers a yield of 0% to investors and pays a quarterly dividend of $0.01 per share. Summerset Group Holdings pays 9.87% of its earnings as a dividend. Green Cross Health pays out 441.92% of its earnings as a dividend. Summerset Group Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future, but Green Cross Health's is not.
-
Which has Better Financial Ratios SMGRF or PRCXF?
Summerset Group Holdings quarterly revenues are --, which are smaller than Green Cross Health quarterly revenues of --. Summerset Group Holdings's net income of -- is lower than Green Cross Health's net income of --. Notably, Summerset Group Holdings's price-to-earnings ratio is 11.05x while Green Cross Health's PE ratio is 13.94x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Summerset Group Holdings is 11.74x versus 0.32x for Green Cross Health. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMGRFSummerset Group Holdings11.74x 11.05x -- -- PRCXFGreen Cross Health0.32x 13.94x -- --
-
Which has Higher Returns SMGRF or RHCGF?
Ryman Healthcare has a net margin of -- compared to Summerset Group Holdings's net margin of --. Summerset Group Holdings's return on equity of 12.83% beat Ryman Healthcare's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital SMGRFSummerset Group Holdings-- -- $2.6B RHCGFRyman Healthcare-- -- -- -
What do Analysts Say About SMGRF or RHCGF?
Summerset Group Holdings has a consensus price target of --, signalling downside risk potential of --. On the other hand Ryman Healthcare has an analysts' consensus of -- which suggests that it could fall by --. Given that Summerset Group Holdings has higher upside potential than Ryman Healthcare, analysts believe Summerset Group Holdings is more attractive than Ryman Healthcare.
Company Buy Ratings Hold Ratings Sell Ratings SMGRFSummerset Group Holdings0 0 0 RHCGFRyman Healthcare0 0 0 -
Is SMGRF or RHCGF More Risky?
Summerset Group Holdings has a beta of -0.401, which suggesting that the stock is 140.118% less volatile than S&P 500. In comparison Ryman Healthcare has a beta of 0.598, suggesting its less volatile than the S&P 500 by 40.193%.
-
Which is a Better Dividend Stock SMGRF or RHCGF?
Summerset Group Holdings has a quarterly dividend of $0.08 per share corresponding to a yield of 1.55%. Ryman Healthcare offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Summerset Group Holdings pays 9.87% of its earnings as a dividend. Ryman Healthcare pays out -- of its earnings as a dividend. Summerset Group Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios SMGRF or RHCGF?
Summerset Group Holdings quarterly revenues are --, which are smaller than Ryman Healthcare quarterly revenues of --. Summerset Group Holdings's net income of -- is lower than Ryman Healthcare's net income of --. Notably, Summerset Group Holdings's price-to-earnings ratio is 11.05x while Ryman Healthcare's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Summerset Group Holdings is 11.74x versus -- for Ryman Healthcare. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income SMGRFSummerset Group Holdings11.74x 11.05x -- -- RHCGFRyman Healthcare-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will JP Morgan’s AI Advisor Be a Winner?
JPMorgan Chase is rolling out “JPM WealthAI for high-net-worth clients.…
Is Revolve Group Stock a Buy, Sell or Hold?
Recently, Revolve Group (NYSE:RVLV) management delivered some fairly positive business…
Stock Ideas
Sell
45
Is AAPL Stock a Buy?
Market Cap: $3T
P/E Ratio: 33x
Buy
53
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Sell
50
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 38x
Alerts
Buy
52
RGC alert for Apr 12
Regencell Bioscience Holdings [RGC] is up 29.14% over the past day.
Buy
52
SLP alert for Apr 12
Simulations Plus [SLP] is up 26.73% over the past day.
Buy
89
GDXU alert for Apr 12
MicroSectors Gold Miners 3X Leveraged ETN [GDXU] is up 15.9% over the past day.
